Merck's new covid pill linked to virus mutations, study finds
Viral samples collected from dozens of covid patients suggest that Merck & Co.’s new anti-viral covid drug Lagevrio (molnupiravir) is triggering the formation of new “strains” of the disease. A preprint study compiled by researchers from the U.S.-based Fra...
And this comes as a surprise? Dr Tennpenny cautioned this in spring of 2020!